Goodwin Procter advised Deciphera Pharmaceuticals, and Davis Polk advised the joint book-running managers involved in the offering.Deciphera Pharmaceuticals Inc. announced a $135.1 million SEC-registered common stock offering….
Deciphera Pharmaceuticals’ $135.1 Million Common Stock Offering
![](https://globallegalchronicle.com/wp-content/uploads/2023/02/deciphera-pharmaceuticals-135-1-million-common-stock-offering_63e0b5068d2ea.jpeg)